A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
How We Diagnose Gynecological Cancers Bookmark and Share

How We Diagnose Gynecological Cancers

An accurate and thorough diagnosis is important so that your City of Hope gynecologic oncology team can develop the best treatment plan for you. Your highly skilled team will use the most advanced and powerful diagnostic imaging technologies and laboratory techniques to plan your personalized treatment.

Imaging
 
Imaging studies give your gynecologic oncology team important information about changes that may be occurring in your reproductive organs.
 
Computed tomography (CT) scan
This procedure uses a computer connected to an X-ray machine to obtain detailed pictures of areas inside the body. A dye may be used to help visualize organs or tissues more clearly.
 
Positron emission tomography (PET) scan
PET scan uses a small amount of radioactive substance to look for evidence of cancer in the body.

Magnetic resonance imaging (MRI) scan
Women who are at extremely high risk for developing gynecologic cancer because of family history, genetics or prior treatment may require closer screening with a pelvic MRI. A pelvic MRI scan is a highly sensitive imaging test that uses powerful magnets and radio waves to create pictures of the reproductive organs and surrounding tissue. It does not use radiation.
 
Ultrasound
Ultrasound uses high-frequency sound waves to examine reproductive organs. An ultrasound may be used to distinguish between a solid mass, which may be cancer, and a fluid-filled cyst, which is usually not cancer. For a better view of the ovaries, a special ultrasound device may be inserted into the vagina (transvaginal ultrasound).

Biopsy
 
A biopsy is a test in which a sample of tissue or fluid is obtained through a needle or by removing a piece of tumor, which is then examined using a microscope. By examining the piece of tumor under the microscope, we can answer questions about the specific composition of the tissue.
 
Blood tests
 
The laboratory may check the level of several substances, including Cancer Antigen 125, which is found on the surface of ovarian cancer cells and on some normal tissues. A high CA-125 level could be a sign of ovarian cancer or other conditions. The CA-125 test is not used alone to diagnose ovarian cancer. This test is approved by the Food and Drug Administration for monitoring a woman's response to ovarian cancer treatment and for detecting its return after treatment.

How We Diagnose Gynecological Cancers

How We Diagnose Gynecological Cancers

An accurate and thorough diagnosis is important so that your City of Hope gynecologic oncology team can develop the best treatment plan for you. Your highly skilled team will use the most advanced and powerful diagnostic imaging technologies and laboratory techniques to plan your personalized treatment.

Imaging
 
Imaging studies give your gynecologic oncology team important information about changes that may be occurring in your reproductive organs.
 
Computed tomography (CT) scan
This procedure uses a computer connected to an X-ray machine to obtain detailed pictures of areas inside the body. A dye may be used to help visualize organs or tissues more clearly.
 
Positron emission tomography (PET) scan
PET scan uses a small amount of radioactive substance to look for evidence of cancer in the body.

Magnetic resonance imaging (MRI) scan
Women who are at extremely high risk for developing gynecologic cancer because of family history, genetics or prior treatment may require closer screening with a pelvic MRI. A pelvic MRI scan is a highly sensitive imaging test that uses powerful magnets and radio waves to create pictures of the reproductive organs and surrounding tissue. It does not use radiation.
 
Ultrasound
Ultrasound uses high-frequency sound waves to examine reproductive organs. An ultrasound may be used to distinguish between a solid mass, which may be cancer, and a fluid-filled cyst, which is usually not cancer. For a better view of the ovaries, a special ultrasound device may be inserted into the vagina (transvaginal ultrasound).

Biopsy
 
A biopsy is a test in which a sample of tissue or fluid is obtained through a needle or by removing a piece of tumor, which is then examined using a microscope. By examining the piece of tumor under the microscope, we can answer questions about the specific composition of the tissue.
 
Blood tests
 
The laboratory may check the level of several substances, including Cancer Antigen 125, which is found on the surface of ovarian cancer cells and on some normal tissues. A high CA-125 level could be a sign of ovarian cancer or other conditions. The CA-125 test is not used alone to diagnose ovarian cancer. This test is approved by the Food and Drug Administration for monitoring a woman's response to ovarian cancer treatment and for detecting its return after treatment.
Quick Links
Gynecological Cancers News
Cooper Finkel Women’s Health Center
Many gynecological cancer and breast cancer  services at City of Hope are provided at the Rita Cooper Finkel and J. William Finkel Women's Health Center. Here, women receive the highest quality care, whether seeking prevention and screening services or coping with a cancer diagnosis.
Tips, tools and resources to help you and your family cope with the issues that arise during and after cancer treatment.
As a leader in cancer research, our goal is to bring the latest scientific findings into medical practice as quickly as possible.
Medical Minute
Listen to the Medical Minute Gynecological Cancers with
Dr. Robert J. Morgan, co-director of the City of Hope gynecological cancers program.
 


NEWS & UPDATES
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...
  • Neural stem cells have a natural ability to seek out cancer cells in the brain. Recent research from the laboratories of Michael Barish, Ph.D., and Karen Aboody, M.D., may offer a new explanation for this attraction between stem cells and tumors. Prior to joining City of Hope, Aboody, now a professor in the Dep...
  • The American Society of Clinical Oncology, a group that includes more than 40,000 cancer specialists around the country, recently issued a list of the five most profound cancer advances over the past five decades. Near the top of the list was the introduction of chemotherapy for testicular cancer. To many in th...
  • “The dying, as a group, have been horribly underserved.” So says Bonnie Freeman, R.N., D.N.P., A.N.P.-B.C., A.C.H.P.N., a nurse practitioner in the Department of Supportive Care Medicine at City of Hope. After nearly 25 years, primarily in critical care nursing, Freeman saw that the needs of the dying were ofte...
  • “Are we the only ones who feel this way?” Courtney Bitz, L.C.S.W., a social worker in the Sheri & Les Biller Patient and Family Resource Center at City of Hope, often hears this question from couples trying to cope with a breast cancer diagnosis and still keep their relationship strong. The ques...
  • Diabetes investigators at City of Hope are studying the full trajectory of diabetes and metabolic disorders, as well as complications of the disease. One especially promising approach focuses on proteins known as growth factors. Led by Fouad Kandeel, M.D., Ph.D., chair and professor of the Department of Clinica...
  • Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades ago, in 1996, the National Comprehensive Cancer Network (NCCN) published its first guidelines for treatment of acute myeloid leukemia, or AML. Margaret O’Donnell, M.D., assoc...
  • Children diagnosed with cancer are more likely than ever before to survive the disease, but with a potential new set of health problems caused by the cancer treatment itself. Those problems can particularly affect the heart, and as doctors and other health care workers try to assess how best to care for this sp...
  • Karen Reckamp, M.D., M.S., has an office next to my own, and we often see patients at the same time. As such, I’ve gotten to know her quite well over the years, and I’ve also gotten a glimpse of many of her patients. She specializes in lung cancer, and most of her patients have tumors […]
  • Today is National Doctors Day, the official day to recognize, thank and celebrate the tremendous work physicians do each and every day. Launched in 1991 via a presidential proclamation from then-President George Bush, the observance offers a chance to reflect on the qualities that define truly great medical car...
  • When considering cancer risk, categories like “women’s cancers” and “men’s cancers” may not matter. A complete medical history, especially of first-degree relatives, must be considered when evaluating risk. A new study drives home that fact. Published in the journal Cancer, the study found a link between a fami...
  • Precision medicine holds promise – on that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers. It can’t be. Researchers and scientists are st...
  • Frank Di Bella, 70, is on a mission: Find a cure for metastatic bladder cancer. It’s just possible he might. Although Di Bella isn’t a world-renowned physician, cancer researcher or scientist, he knows how to make things happen. For more than 20 years, he served as chairman of annual fundraising gal...
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...